Drug checking services at music festivals and events in a Canadian setting.
British Columbia
/ epidemiology
Central Nervous System Stimulants
/ analysis
Drug Contamination
/ statistics & numerical data
Fentanyl
/ analysis
Hallucinogens
/ analysis
Harm Reduction
Holidays
Humans
Illicit Drugs
/ analysis
Immunoassay
/ methods
Levamisole
/ analysis
Music
Phenacetin
/ analysis
Reproducibility of Results
Spectroscopy, Fourier Transform Infrared
/ statistics & numerical data
Substance Abuse Detection
/ methods
Drug checking
Festivals
Harm reduction
Public health
Journal
Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587
Informations de publication
Date de publication:
01 12 2019
01 12 2019
Historique:
received:
19
03
2019
revised:
31
07
2019
accepted:
05
08
2019
pubmed:
13
10
2019
medline:
1
7
2020
entrez:
13
10
2019
Statut:
ppublish
Résumé
Drug checking is a harm reduction intervention that allows for identification of drug composition. The objective of the study was to assess drug market components and concordance between expected substance reported by clients and results from point-of-care drug checking at music festivals and events in British Columbia. From July to September 2018, we provided drug checking services at four events using combination Fourier Transform Infrared (FTIR) spectroscopy and fentanyl immunoassay strips. We measured concordance between expected substance as reported by clients to the results from the FTIR/fentanyl immunoassay strip and tracked unexpected adulterants. In total, 336 checks were completed. Most samples were expected by clients to be psychedelics (69.3%) or stimulants (19.6%). Of the 233 psychedelic samples, 169 (72.5%) contained the expected, unadulterated substance, and 27 (11.6%) contained additional contaminants. Of 66 stimulant samples, 41 (62.1%) contained expected substance, while 24 (36.4%) contained additional contaminants. Unexpected adulterants such as fentanyl, levamisole, and phenacetin were also found, in addition to several novel psychoactive substances. We found a large proportion of substances that contained unexpected adulterants. Our findings highlight the value of continued drug checking and will be helpful in designing future harm reduction interventions in similar contexts.
Identifiants
pubmed: 31605958
pii: S0376-8716(19)30366-7
doi: 10.1016/j.drugalcdep.2019.107589
pii:
doi:
Substances chimiques
Central Nervous System Stimulants
0
Hallucinogens
0
Illicit Drugs
0
Levamisole
2880D3468G
Phenacetin
ER0CTH01H9
Fentanyl
UF599785JZ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
107589Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.